Drug companies are fixated on proving their drugs extend survival or delay cancer progression by as little as a few months or weeks. This could gain them FDA approval and potentially billions in sales.
via blogs.forbes.com
Drug companies are fixated on proving their drugs extend survival or delay cancer progression by as little as a few months or weeks. This could gain them FDA approval and potentially billions in sales.
No comments:
Post a Comment